Follow
Alejandro Jiménez-Sánchez
Alejandro Jiménez-Sánchez
Postdoctoral Research Fellow, Computational & Systems Biology Program, Sloan Kettering Institute
Verified email at mskcc.org - Homepage
Title
Cited by
Cited by
Year
Heterogeneous tumor-immune microenvironments among differentially growing metastases in an ovarian cancer patient
A Jiménez-Sánchez, D Memon, S Pourpe, H Veeraraghavan, Y Li, ...
Cell 170 (5), 927-938. e20, 2017
4722017
UVB-induced tumor heterogeneity diminishes immune response in melanoma
Y Wolf, O Bartok, S Patkar, GB Eli, S Cohen, K Litchfield, R Levy, ...
Cell 179 (1), 219-235. e21, 2019
3572019
Unraveling tumor–immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy
A Jiménez-Sánchez, P Cybulska, KLV Mager, S Koplev, O Cast, ...
Nature Genetics 52 (6), 582-593, 2020
1872020
Comprehensive benchmarking and integration of tumor microenvironment cell estimation methods
A Jiménez-Sánchez, O Cast, ML Miller
Cancer Research 79 (24), 6238-6246, 2019
1492019
Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8
T Walle, JA Kraske, B Liao, B Lenoir, C Timke, E von Bohlen und Halbach, ...
Science advances 8 (12), eabh4050, 2022
912022
Lack of detectable neoantigen depletion signals in the untreated cancer genome
J Van den Eynden, A Jiménez-Sánchez, ML Miller, E Larsson
Nature genetics 51 (12), 1741-1748, 2019
692019
Mutational Analysis Identifies Therapeutic Biomarkers in Inflammatory Bowel Disease–Associated Colorectal Cancers
S Din, K Wong, MF Mueller, A Oniscu, J Hewinson, CJ Black, ML Miller, ...
Clinical Cancer Research 24 (20), 5133-5142, 2018
402018
Multi-site clonality analysis uncovers pervasive heterogeneity across melanoma metastases
R Rabbie, N Ansari-Pour, O Cast, D Lau, F Scott, SJ Welsh, C Parkinson, ...
Nature communications 11 (1), 4306, 2020
322020
Integrated multi-tumor radio-genomic marker of outcomes in patients with high serous ovarian carcinoma
H Veeraraghavan, HA Vargas, A Jimenez-Sanchez, M Micco, E Mema, ...
Cancers 12 (11), 3403, 2020
302020
Co-stimulation with stem cell factor and erythropoietin enhances migration of c-Kit expressing cervical cancer cells through the sustained activation of ERK1/2
C Aguilar, C Aguilar, R Lopez-Marure, A Jiménez-Sánchez, ...
Molecular medicine reports 9 (5), 1895-1902, 2014
262014
Coevolution of RAC small GTPases and their regulators GEF proteins
A Jiménez-Sánchez
Evolutionary Bioinformatics 12, EBO. S38031, 2016
72016
Lack of detectable neoantigen depletion in the untreated cancer genome
JV Eynden, A Jiménez-Sánchez, ML Miller, E Larsson
BioRxiv, 478263, 2018
52018
Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations
N Bharti, L Santos, M Davyt, S Behrmann, M Eichholtz, ...
Nature Communications 15 (1), 2957, 2024
42024
Multi-site clonality analyses uncovers pervasive subclonal heterogeneity and branching evolution across melanoma metastases
R Rabbie, N Ansari-Pour, O Cast, D Lau, F Scott, SJ Welsh, C Parkinson, ...
BioRxiv, 848390, 2019
32019
Characterisation of the tumour microenvironment in ovarian cancer
A Jiménez Sánchez
22019
Tumor progression and tumor microenvironment of pancreas cancer ascites revealed by scRNA-seq and spatial transcriptomics
S Umeda, ER Karnoub, F Balogun, A Jiménez-Sánchez, ...
Cancer Research 84 (6_Supplement), 1273-1273, 2024
2024
Optimal tumor metastatic gene programs in pancreatic cancer
A Jiménez-Sánchez, Y Xie, R Sharma, TY Chu, V Liu, W Park, A Hayashi, ...
Cancer Research 82 (12_Supplement), 279-279, 2022
2022
La región 3¿ UTR del genoma de WNV es una excelente diana para el desarrollo de fármacos antivirales.
SE Ramos-Lorente, B Berzal-Herranz, A Jiménez-Sánchez, ...
2022
The 3’UTR of WNV genome is an excellent target for antiviral drugs
SE Ramos-Lorente, B Berzal-Herranz, A Jiménez-Sánchez, ...
MDPI, 2021
2021
Implicaciones funcionales de dominios conservados de genomas RNA
A Berzal-Herranz, A Jiménez Sánchez
2021
The system can't perform the operation now. Try again later.
Articles 1–20